The THIOMAB brand, founded in 2008 (United States), from 640 sister brands and 17477 competing brands. THIOMAB is owned by ROCHE HOLDING, listed on the stock exchange of Zurich Its International Securities Identification Number (ISIN) is CH0012032048. THIOMAB belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
ROCHE HOLDING
(THIOMAB)
over 5 years*
CHF 182.23